A novel proteolytic system of pulmonary inflammation

肺部炎症的新型蛋白水解系统

基本信息

  • 批准号:
    7992739
  • 负责人:
  • 金额:
    $ 37.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-02 至 2015-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In this proposal, we describe a new pathway signaling neutrophil (PMN) influx and damage to the airways that may play a role as an initiator or cofactor for chronic inflammatory lung diseases such as cystic fibrosis (CF). We have previously demonstrated that proline-glycine-proline (PGP) peptides can cause a robust PMN influx into the airways of mice; this cellular specificity is due to structural relatedness to a receptor binding domain of CXC chemokines such as IL-8. The PI has shown that PGP is released from collagen by a stepwise process initially involving matrix metalloproteases (MMP)-8 and/or 9 with prolyl endopeptidase (PE) catalyzing the final reaction. Recently, the PI's lab has shown that PE is found in neutrophils and stimulated PMNs, when incubated on collagen, can cause notable PGP generation. Although work from the PI's group has demonstrated that PGP is found in CF airway secretions, the impact of PGP peptides in augmenting inflammatory responses in CF lung disease is not currently known. This grant application aims to address this by first investigating the impact of CXC ligands (including PGP and N-(-PGP) as a novel mechanism for the generation of PGP in ex vivo studies and further examining the specific intracellular pathways utilized for protease release from neutrophils. Then, these observations will be taken to a unique mouse model of CF lung disease, the (-ENaC overexpressor mouse (Specific Aim 2), to determine the impact of components of this inflammatory pathway on the phenotype and inflammatory response observed in this murine model. Determination of these fundamental pathways driving protease regulation/release have important implications to patients with chronic inflammatory disease, such as CF, where inflammatory stimuli such as CXC chemokines, are in increased abundance even during periods of disease stability. Our preliminary evidence suggests that at the beginning of an inpatient CF exacerbation, PGP levels are elevated but do decline by the end of hospitalization. However, even with this clinical improvement, PGP levels are still elevated compared to non-disease controls, suggesting that there continues to be ongoing inflammation in these airways. In the final aim of this proposal, we examine if clinically stable CF individuals have elevated levels of PGP and proteases in both sputum and serum. If so, it is possible that their elevation and persistence may predict the development of future disease exacerbations, serving as a unique biomarker for CF lung disease. The findings generated from these aims may have profound translational implications not only to CF lung disease but potentially to other neutrophilic inflammatory conditions. PUBLIC HEALTH RELEVANCE: We have proposed a series of complementary experimental aims to examine the impact of PGP-containing peptides and their generating proteases in cystic fibrosis (CF). The implications of these findings may be broadly applicable to other conditions with prominent neutrophilic inflammation and extracellular matrix breakdown.
描述(由申请人提供):在本提案中,我们描述了一种介导中性粒细胞(PMN)内流和气道损伤的新途径,该途径可能作为慢性炎症性肺部疾病(如囊性纤维化(CF))的启动剂或辅助因子。我们之前已经证明脯氨酸-甘氨酸-脯氨酸(PGP)肽可以导致PMN大量流入小鼠气道;这种细胞特异性是由于CXC趋化因子(如IL-8)的受体结合域在结构上的相关性。PI表明,PGP从胶原蛋白中释放是一个循序渐进的过程,最初涉及基质金属蛋白酶(MMP)-8和/或9,脯氨酸内肽酶(PE)催化最终反应。最近,PI的实验室已经证明,PE存在于中性粒细胞和受刺激的PMNs中,当在胶原蛋白上孵育时,可以引起显著的PGP生成。尽管PI小组的工作已经证明在CF气道分泌物中发现了PGP,但PGP肽在CF肺部疾病中增强炎症反应的影响目前尚不清楚。该资助申请旨在通过首先研究CXC配体(包括PGP和N-(-PGP))作为体外研究中PGP产生的新机制的影响,并进一步研究用于中性粒细胞释放蛋白酶的特定细胞内途径来解决这一问题。然后,这些观察结果将被带到一种独特的CF肺部疾病小鼠模型,(-ENaC过表达小鼠(Specific Aim 2),以确定该炎症途径的成分对该小鼠模型中观察到的表型和炎症反应的影响。确定这些驱动蛋白酶调节/释放的基本途径对慢性炎症性疾病(如CF)患者具有重要意义,其中炎症刺激(如CXC趋化因子)即使在疾病稳定期间也会增加丰度。我们的初步证据表明,在住院CF恶化开始时,PGP水平升高,但在住院结束时确实下降。然而,即使有这种临床改善,与非疾病对照相比,PGP水平仍然升高,这表明这些气道中仍存在持续的炎症。在本提案的最终目的中,我们检查临床稳定的CF患者是否有痰和血清中PGP和蛋白酶水平升高。如果是这样,它们的升高和持续可能预测未来疾病恶化的发展,作为CF肺病的独特生物标志物。从这些目标产生的发现可能具有深远的转化意义,不仅对CF肺病,而且可能对其他中性粒细胞炎症性疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AMIT GAGGAR其他文献

AMIT GAGGAR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AMIT GAGGAR', 18)}}的其他基金

Neutrophil Exosomes: New Pathogenic Entities in COPD
中性粒细胞外泌体:慢性阻塞性肺病的新致病实体
  • 批准号:
    10657577
  • 财政年份:
    2020
  • 资助金额:
    $ 37.79万
  • 项目类别:
Role of heme and PGP matrikines in lung inflammation
血红素和 PGP 基质素在肺部炎症中的作用
  • 批准号:
    10693865
  • 财政年份:
    2020
  • 资助金额:
    $ 37.79万
  • 项目类别:
Neutrophil Exosomes: New Pathogenic Entities in COPD
中性粒细胞外泌体:慢性阻塞性肺病的新致病实体
  • 批准号:
    10480885
  • 财政年份:
    2020
  • 资助金额:
    $ 37.79万
  • 项目类别:
Role of heme and PGP matrikines in lung inflammation
血红素和 PGP 基质素在肺部炎症中的作用
  • 批准号:
    10247734
  • 财政年份:
    2020
  • 资助金额:
    $ 37.79万
  • 项目类别:
Role of heme and PGP matrikines in lung inflammation
血红素和 PGP 基质素在肺部炎症中的作用
  • 批准号:
    10028641
  • 财政年份:
    2020
  • 资助金额:
    $ 37.79万
  • 项目类别:
Role of heme and PGP matrikines in lung inflammation
血红素和 PGP 基质素在肺部炎症中的作用
  • 批准号:
    10468254
  • 财政年份:
    2020
  • 资助金额:
    $ 37.79万
  • 项目类别:
Neutrophil Exosomes: New Pathogenic Entities in COPD
中性粒细胞外泌体:慢性阻塞性肺病的新致病实体
  • 批准号:
    10467984
  • 财政年份:
    2020
  • 资助金额:
    $ 37.79万
  • 项目类别:
Prolyl Endopeptidase-Mediated Matrix Remodeling and Inflammation in COPD
脯氨酰内肽酶介导的慢性阻塞性肺病基质重塑和炎症
  • 批准号:
    8734624
  • 财政年份:
    2014
  • 资助金额:
    $ 37.79万
  • 项目类别:
Training Program in Lung Biology and Translational Medicine
肺生物学和转化医学培训项目
  • 批准号:
    10442539
  • 财政年份:
    2010
  • 资助金额:
    $ 37.79万
  • 项目类别:
Training Program in Lung Biology and Translational Medicine
肺生物学和转化医学培训计划
  • 批准号:
    9756439
  • 财政年份:
    2010
  • 资助金额:
    $ 37.79万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了